<p>根據 AlphaQuest LLC 最近向證券交易委員會（SEC）披露的信息，該公司在第三季度將其在 Global Medical REIT Inc.（NYSE:GMRE - 免費報告）的持股減少了 80.9%。在該季度出售了 34,611 股後，機構投資者持有該公司 8,164 股股票。截至其最近的 SEC 備案，AlphaQuest LLC 持有 Global Medical REIT 的股份佔比為 0.06%，價值約為 275,000 美元。</p>
<p>獲取 <strong>Global Medical REIT</strong> 警報：</p>
<ul>
<li>Global Medical：該 REIT 剛剛獲得 30% 的目標價格</li>
</ul>
<p>其他對沖基金最近也調整了對該公司的持股。紐約州教師退休系統在第三季度新購入了 Global Medical REIT 的股份，價值約為 39,000 美元。Tower Research Capital LLC TRC 在第二季度將其在 Global Medical REIT 的持股增加了 70.3%。Tower Research Capital LLC TRC 目前持有該公司 7,379 股股票，價值 51,000 美元，此前在上個季度又購買了 3,046 股。Samalin Investment Counsel LLC 在第三季度購買了 Global Medical REIT 的新股份，價值約為 273,000 美元。Metis Global Partners LLC 在第二季度購買了 Global Medical REIT 的新股份，價值 72,000 美元。最後，Strs Ohio 在第一季度購買了 Global Medical REIT 的新股份，價值約為 95,000 美元。機構投資者和對沖基金持有該公司 57.52% 的股票。</p>
<h2>內部買賣</h2>
<p>在其他 Global Medical REIT 的新聞中，首席執行官 Mark Okey Decker, Jr.於 11 月 14 日星期五購買了 10,000 股該公司的股票。每股購買價格為 32.58 美元，總價值為 325,800.00 美元。收購完成後，首席執行官直接持有該公司 44,774 股股票，價值約為 1,458,736.92 美元。此次交易使其持股增加了 28.76%。該交易已在 SEC 的法律文件中披露，公眾可以通過 SEC 網站訪問。當前 8.50% 的股票由公司內部人士持有。</p>
<h2>Global Medical REIT 下跌 0.6%</h2>
<p>週二，NYSE GMRE 的開盤價為 36.41 美元。該公司的市值為 4.8819 億美元，市盈率為-145.62，貝塔值為 1.18。Global Medical REIT Inc.的 12 個月低點為 29.05 美元，12 個月高點為 45.75 美元。該公司的債務與股本比率為 1.65，流動比率為 0.52，速動比率為 0.52。該公司的 50 日移動平均線為 34.72 美元，200 日移動平均線為 34.16 美元。</p>
<h2>Global Medical REIT 宣佈分紅</h2>
<p>該公司最近還披露了季度分紅，已於 1 月 9 日星期五支付。12 月 19 日的股東獲得了 0.75 美元的分紅。這相當於年化 3.00 美元的分紅，收益率為 8.2%。該分紅的除息日期為 12 月 19 日。Global Medical REIT 的派息比率目前為-1,200.00%。</p>
<h2>分析師評級變動</h2>
<p>幾位分析師最近對 GMRE 股票進行了評估。JMP Securities 在 10 月 13 日的報告中對 Global Medical REIT 設定了 40.00 美元的目標價格，並給予該公司 “市場表現優於大盤” 的評級。Robert W. Baird 將 Global Medical REIT 的目標價格從 45.00 美元下調至 41.00 美元，並在 11 月 11 日的報告中給予該公司 “中性” 評級。Weiss Ratings 在 1 月 21 日的報告中將 Global Medical REIT 的評級從 “賣出（d+）” 上調至 “持有（c-）”。花旗集團在 10 月 13 日的研究報告中將 Global Medical REIT 的評級上調至 “優於大盤”。最後，Wall Street Zen 在 11 月 8 日的研究報告中將 Global Medical REIT 的評級從 “持有” 下調至 “賣出”。一位投資分析師給予該股票 “強烈買入” 評級，三位分析師給予 “買入” 評級，三位分析師給予 “持有” 評級。根據 MarketBeat.com 的數據，該股票的平均評級為 “適度買入”，共識目標價格為 41.50 美元。</p>
<p><strong>獲取我們關於 GMRE 的最新報告</strong></p>
<h2>關於 Global Medical REIT</h2>
<p>（免費報告）</p>
<p>Global Medical REIT NYSE: GMRE 是一家專注於擁有和管理美國醫療相關物業的房地產投資信託。該公司收購、開發和租賃多樣化的醫療辦公樓、門診設施、長期護理中心和其他專業醫療房地產。通過專注於必要的醫療資產，Global Medical REIT 旨在在三網和修訂的毛租賃結構下產生穩定的長期租金收入。</p>
<p>自 2016 年成立和 2017 年首次公開募股以來，該公司一直追求收購增長戰略，目標是具有強大人口趨勢和現代醫療設施供應有限的市場。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們更看好的股票超過 Global Medical REIT</li>
<li>沒有人談論的購買狂潮</li>
<li>如何每週收集 500-800 美元（黑石的系統）</li>
<li>你的銀行賬户不再安全</li>
<li>特朗普的 AI 秘密：比 Nvidia 快 100 倍</li>
<li>新法律：國會批准數字美元的設立？</li>
</ul>
<p><strong>想看看其他對沖基金持有 GMRE 的情況嗎？</strong> 訪問 HoldingsChannel.com，獲取 Global Medical REIT Inc.（NYSE:GMRE - 免費報告）的最新 13F 備案和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UCNlN5bWJvbD1HTVJF?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UCNlN5bWJvbD1HTVJF"/></p>
<p><em>此即時新聞警報由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Global Medical REIT 嗎？</h2>
<p>在考慮 Global Medical REIT 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Global Medical REIT 並不在名單上。</p>
<p>雖然 Global Medical REIT 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

GMRE

<p>AlphaQuest LLC 在第三季度將其在 Global Medical REIT Inc.（紐約證券交易所代碼：GMRE）的持股比例減少了 80.9%，目前持有 8,164 股，價值 275,000 美元。其他機構投資者也調整了他們的持倉。首席執行官 Mark Okey Decker, Jr. 購買了 10,000 股，增持幅度為 28.76%。GMRE 股票開盤價為 36.41 美元，市值為 4.8819 億美元。該公司最近宣佈季度股息為 0.75 美元，收益率為 8.2%。分析師對 GMRE 的評級不一，普遍目標價為 41.50 美元</p>

<p>AlphaQuest LLC cut its holdings in Global Medical REIT Inc. (NYSE:GMRE - Free Report) by 80.9% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,164 shares of the company's stock after selling 34,611 shares during the quarter. AlphaQuest LLC owned 0.06% of Global Medical REIT worth $275,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>根據 AlphaQuest LLC 最近向證券交易委員會（SEC）披露的信息，該公司在第三季度將其在 Global Medical REIT Inc.（NYSE:GMRE - 免費報告）的持股減少了 80.9%。在該季度出售了 34,611 股後，機構投資者持有該公司 8,164 股股票。截至其最近的 SEC 備案，AlphaQuest LLC 持有 Global Medical REIT 的股份佔比為 0.06%，價值約為 275,000 美元。</p>
</div><p>Get <strong>Global Medical REIT</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Global Medical REIT</strong> 警報：</p>
</div><ul>
<li>Global Medical: This REIT Just Got a 30% Price Target</li>
</ul>
<div class="lb-trans"><ul>
<li>Global Medical：該 REIT 剛剛獲得 30% 的目標價格</li>
</ul>
</div><p>Other hedge funds have also recently modified their holdings of the company. New York State Teachers Retirement System acquired a new position in shares of Global Medical REIT during the 3rd quarter worth approximately $39,000. Tower Research Capital LLC TRC lifted its position in Global Medical REIT by 70.3% in the second quarter. Tower Research Capital LLC TRC now owns 7,379 shares of the company's stock valued at $51,000 after buying an additional 3,046 shares during the last quarter. Samalin Investment Counsel LLC purchased a new position in shares of Global Medical REIT during the 3rd quarter worth approximately $273,000. Metis Global Partners LLC purchased a new position in shares of Global Medical REIT during the second quarter worth $72,000. Finally, Strs Ohio purchased a new stake in Global Medical REIT during the first quarter worth about $95,000. Institutional investors and hedge funds own 57.52% of the company's stock.</p>
<div class="lb-trans"><p>其他對沖基金最近也調整了對該公司的持股。紐約州教師退休系統在第三季度新購入了 Global Medical REIT 的股份，價值約為 39,000 美元。Tower Research Capital LLC TRC 在第二季度將其在 Global Medical REIT 的持股增加了 70.3%。Tower Research Capital LLC TRC 目前持有該公司 7,379 股股票，價值 51,000 美元，此前在上個季度又購買了 3,046 股。Samalin Investment Counsel LLC 在第三季度購買了 Global Medical REIT 的新股份，價值約為 273,000 美元。Metis Global Partners LLC 在第二季度購買了 Global Medical REIT 的新股份，價值 72,000 美元。最後，Strs Ohio 在第一季度購買了 Global Medical REIT 的新股份，價值約為 95,000 美元。機構投資者和對沖基金持有該公司 57.52% 的股票。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>內部買賣</h2>
</div><p>In other Global Medical REIT news, CEO Mark Okey Decker, Jr. bought 10,000 shares of the business's stock in a transaction on Friday, November 14th. The shares were purchased at an average price of $32.58 per share, with a total value of $325,800.00. Following the completion of the acquisition, the chief executive officer directly owned 44,774 shares of the company's stock, valued at approximately $1,458,736.92. The trade was a 28.76% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 8.50% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他 Global Medical REIT 的新聞中，首席執行官 Mark Okey Decker, Jr.於 11 月 14 日星期五購買了 10,000 股該公司的股票。每股購買價格為 32.58 美元，總價值為 325,800.00 美元。收購完成後，首席執行官直接持有該公司 44,774 股股票，價值約為 1,458,736.92 美元。此次交易使其持股增加了 28.76%。該交易已在 SEC 的法律文件中披露，公眾可以通過 SEC 網站訪問。當前 8.50% 的股票由公司內部人士持有。</p>
</div><h2>Global Medical REIT Trading Down 0.6%</h2>
<div class="lb-trans"><h2>Global Medical REIT 下跌 0.6%</h2>
</div><p>NYSE GMRE opened at $36.41 on Tuesday. The company has a market cap of $488.19 million, a P/E ratio of -145.62 and a beta of 1.18. Global Medical REIT Inc. has a 12 month low of $29.05 and a 12 month high of $45.75. The company has a debt-to-equity ratio of 1.65, a current ratio of 0.52 and a quick ratio of 0.52. The company has a 50-day moving average of $34.72 and a 200-day moving average of $34.16.</p>
<div class="lb-trans"><p>週二，NYSE GMRE 的開盤價為 36.41 美元。該公司的市值為 4.8819 億美元，市盈率為-145.62，貝塔值為 1.18。Global Medical REIT Inc.的 12 個月低點為 29.05 美元，12 個月高點為 45.75 美元。該公司的債務與股本比率為 1.65，流動比率為 0.52，速動比率為 0.52。該公司的 50 日移動平均線為 34.72 美元，200 日移動平均線為 34.16 美元。</p>
</div><h2>Global Medical REIT Announces Dividend</h2>
<div class="lb-trans"><h2>Global Medical REIT 宣佈分紅</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 9th. Shareholders of record on Friday, December 19th were issued a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 8.2%. The ex-dividend date of this dividend was Friday, December 19th. Global Medical REIT's payout ratio is currently -1,200.00%.</p>
<div class="lb-trans"><p>該公司最近還披露了季度分紅，已於 1 月 9 日星期五支付。12 月 19 日的股東獲得了 0.75 美元的分紅。這相當於年化 3.00 美元的分紅，收益率為 8.2%。該分紅的除息日期為 12 月 19 日。Global Medical REIT 的派息比率目前為-1,200.00%。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><p>Several analysts recently weighed in on GMRE shares. JMP Securities set a $40.00 target price on shares of Global Medical REIT and gave the company a &#34;market outperform&#34; rating in a report on Monday, October 13th. Robert W. Baird decreased their price objective on Global Medical REIT from $45.00 to $41.00 and set a &#34;neutral&#34; rating for the company in a report on Tuesday, November 11th. Weiss Ratings raised Global Medical REIT from a &#34;sell (d+)&#34; rating to a &#34;hold (c-)&#34; rating in a report on Wednesday, January 21st. Citigroup raised shares of Global Medical REIT to an &#34;outperform&#34; rating in a research note on Monday, October 13th. Finally, Wall Street Zen downgraded Global Medical REIT from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a research note on Saturday, November 8th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat.com, the stock has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $41.50.</p>
<div class="lb-trans"><p>幾位分析師最近對 GMRE 股票進行了評估。JMP Securities 在 10 月 13 日的報告中對 Global Medical REIT 設定了 40.00 美元的目標價格，並給予該公司 “市場表現優於大盤” 的評級。Robert W. Baird 將 Global Medical REIT 的目標價格從 45.00 美元下調至 41.00 美元，並在 11 月 11 日的報告中給予該公司 “中性” 評級。Weiss Ratings 在 1 月 21 日的報告中將 Global Medical REIT 的評級從 “賣出（d+）” 上調至 “持有（c-）”。花旗集團在 10 月 13 日的研究報告中將 Global Medical REIT 的評級上調至 “優於大盤”。最後，Wall Street Zen 在 11 月 8 日的研究報告中將 Global Medical REIT 的評級從 “持有” 下調至 “賣出”。一位投資分析師給予該股票 “強烈買入” 評級，三位分析師給予 “買入” 評級，三位分析師給予 “持有” 評級。根據 MarketBeat.com 的數據，該股票的平均評級為 “適度買入”，共識目標價格為 41.50 美元。</p>
</div><p><strong>Get Our Latest Report on GMRE</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 GMRE 的最新報告</strong></p>
</div><h2>About Global Medical REIT</h2>
<div class="lb-trans"><h2>關於 Global Medical REIT</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Global Medical REIT NYSE: GMRE is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.</p>
<div class="lb-trans"><p>Global Medical REIT NYSE: GMRE 是一家專注於擁有和管理美國醫療相關物業的房地產投資信託。該公司收購、開發和租賃多樣化的醫療辦公樓、門診設施、長期護理中心和其他專業醫療房地產。通過專注於必要的醫療資產，Global Medical REIT 旨在在三網和修訂的毛租賃結構下產生穩定的長期租金收入。</p>
</div><p>Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.</p>
<div class="lb-trans"><p>自 2016 年成立和 2017 年首次公開募股以來，該公司一直追求收購增長戰略，目標是具有強大人口趨勢和現代醫療設施供應有限的市場。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Global Medical REIT</li>
<li>The buying spree that no one is talking about</li>
<li>How to collect $500-$800 weekly (BlackRock's system)</li>
<li>Your Bank Account Is No Longer Safe</li>
<li>Trump’s AI Secret: 100X Faster Than Nvidia</li>
<li>NEW LAW: Congress Approves Setup For Digital Dollar?</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過 Global Medical REIT</li>
<li>沒有人談論的購買狂潮</li>
<li>如何每週收集 500-800 美元（黑石的系統）</li>
<li>你的銀行賬户不再安全</li>
<li>特朗普的 AI 秘密：比 Nvidia 快 100 倍</li>
<li>新法律：國會批准數字美元的設立？</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding GMRE?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Global Medical REIT Inc. (NYSE:GMRE - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對沖基金持有 GMRE 的情況嗎？</strong> 訪問 HoldingsChannel.com，獲取 Global Medical REIT Inc.（NYSE:GMRE - 免費報告）的最新 13F 備案和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdNUkU" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=GMRE"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞警報由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Global Medical REIT Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Global Medical REIT 嗎？</h2>
</div><p>Before you consider Global Medical REIT, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Global Medical REIT 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Global Medical REIT 並不在名單上。</p>
</div><p>While Global Medical REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Global Medical REIT 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

AlphaQuest LLC 降低了其在 Global Medical REIT Inc. $GMRE 中的股份